Live Quote · OTCRLLVFHealthcare· Medical - Pharmaceuticals

Relevium Technologies Inc.

$0.01 0.00%(+$0.00)
TickerSpark Score
47/100
Weak
67
Valuation
55
Profitability
55
Growth
28
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLLVF research report →

52-Week Range0% of range
Low
$0.01
Current
$0.01
High
$0.22

About the company

Relevium Technologies Inc. operates within the health and wellness sector, focusing on identifying, assessing, acquiring, and managing various brands and businesses, primarily through e-commerce channels. The company distributes a range of products, including dietary supplements, nutraceuticals, sports nutrition items, and cosmeceuticals, mainly through its Bioganix online brand.

CEO
Aurelio Useche
IPO
2017
HQ
Montreal, QC, CA

Price Chart

+0.00% · this period
$0.01$0.00$0.00Jul 02Dec 31Jul 02
Valuation
Market Cap
$1.98M
P/E
-0.33
P/S
3.07
P/B
-0.36
EV/EBITDA
-1.29
Div Yield
0.00%
Profitability
Gross Margin
45.37%
Op Margin
-161.49%
Net Margin
-587.57%
ROE
221.45%
ROIC
88.93%
Growth & Income
Revenue
$913.64K · -69.28%
Net Income
$-5,368,336 · 22.55%
EPS
$-0.03 · 30.19%
Op Income
$-1,475,457
FCF YoY
94.11%
Performance & Tape
52W High
$0.22
52W Low
$0.01
50D MA
$0.01
200D MA
$0.01
Beta
2.51
Avg Volume
603.576

Get TickerSpark's AI analysis on RLLVF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · RLLVF

Our RLLVF coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on RLLVF yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate RLLVF report →
Internal Compare

Similar companies

Peers in the same neighborhood.